|
End-of-day quote
Dhaka S.E.
12/11/2026
|
5-day change | 1st Jan Change | ||
| 79.50 BDT | -0.63% |
|
+1.66% | +12.13% |
| 11-08 | The ACME Laboratories Ltd. Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-27 | The ACME Laboratories Ltd. announces Annual dividend, payable on January 21, 2027 | CI |
| Market Cap | 16.82B 135M 122M 113M 102M 192M 12.69B 199M 1.35B 537M 6.78B 505M 494M 21.51B | P/E 2025 |
6.29x | P/E 2026 | 6.51x |
|---|---|---|---|---|---|
| Enterprise Value | 38.74B 310M 281M 260M 234M 442M 29.22B 457M 3.12B 1.24B 15.61B 1.16B 1.14B 49.55B | EV / Sales 2025 |
1.06x | EV / Sales 2026 | 0.95x |
| Free-Float |
51.84% | Yield 2025 |
4.85% | Yield 2026 | - |
| 1 day | -0.63% | ||
| 1 week | +1.66% | ||
| Current month | +2.05% | ||
| 1 month | +3.25% | ||
| 3 months | -4.45% | ||
| 6 months | +4.47% | ||
| Current year | +12.13% |
| 1 week | 77.4 | 81.1 | |
| 1 month | 76.5 | 81.1 | |
| Current year | 70.6 | 88.7 | |
| 1 year | 68.6 | 88.7 | |
| 3 years | 62.6 | 94.5 | |
| 5 years | 62.6 | 111 | |
| 10 years | 54.2 | 122.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 30/09/1995 | |
| Director of Finance/CFO | - | - | |
Asad Shamsuddin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 82 | 17/03/1975 | |
| Director/Board Member | 76 | 15/04/1981 | |
| Chairman | 69 | 05/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.63% | +1.66% | +11.34% | -6.47% | 135M | ||
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | ||
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | ||
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | ||
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | ||
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | ||
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | ||
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | ||
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | ||
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | ||
| Average | +0.18% | +2.11% | +32.99% | +74.38% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +96.50% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 35.94B 287M 261M 241M 217M 410M 27.11B 424M 2.89B 1.15B 14.48B 1.08B 1.06B 45.96B | 41.6B 333M 302M 279M 252M 474M 31.37B 491M 3.35B 1.33B 16.76B 1.25B 1.22B 53.2B |
| Net income | 2.43B 19.43M 17.6M 16.28M 14.69M 27.69M 1.83B 28.66M 196M 77.56M 978M 72.9M 71.36M 3.11B | 2.68B 21.41M 19.4M 17.94M 16.19M 30.51M 2.02B 31.58M 216M 85.46M 1.08B 80.33M 78.63M 3.42B |
| Net Debt | 22.87B 183M 166M 153M 138M 261M 17.25B 270M 1.84B 731M 9.22B 687M 672M 29.25B | 21.92B 175M 159M 147M 133M 250M 16.53B 259M 1.77B 700M 8.83B 658M 644M 28.03B |
Employees
9,025
Sector
Pharmaceuticals
Calendar
11-19
Ex-dividend date - 4 BDT
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | BDT 79.50 | -0.62% | 159,676 |
| 11/11/26 | BDT 80.00 | -0.50% | 279,654 |
| 10/11/26 | BDT 80.40 | +1.52% | 272,519 |
| 09/11/26 | BDT 79.20 | +2.06% | 368,525 |
| 08/11/26 | BDT 77.60 | -0.77% | 114,020 |
- Stock Market
- Stocks
- ACMELAB Stock
Select your edition
All financial news and data tailored to specific country editions
















